van Kan-Davelaar H E, van Hest J C M, Cornelissen J J L M, Koay M S T
Department of Biomolecular Nanotechnology, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.
Br J Pharmacol. 2014 Sep;171(17):4001-9. doi: 10.1111/bph.12662.
The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system-related diseases.
纳米医学领域涉及设计和制造新型纳米载体,用于细胞内递送治疗性物质或用于分子诊断。尽管病毒和噬菌体传统上因具有侵入和感染宿主细胞的能力而为人所知,但在过去十年中,它们已被改造成为极具前景的分子平台,用于多种人类疾病的靶向递送和治疗。病毒的外衣壳具有内在的可生物降解性,完全由蛋白质构建块组成,可以用分子成像试剂、靶向配体和治疗分子进行基因工程或化学工程改造。虽然有几个病毒作为体外分子货物载体的例子,但它们在纳米医学中的应用潜力直到最近才显现出来。在这里,我们重点介绍了病毒设计和工程改造在治疗癌症、细菌感染和免疫系统相关疾病方面的最新进展。